Bicycle Therapeutics (BCYC) Payables (2018 - 2026)

Bicycle Therapeutics' Payables history runs 9 years deep, the most recent figure standing at $6.0 million for Q1 2026.

• Quarterly Payables fell 46.25% year-over-year to $6.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.0 million (down 46.25% YoY) and the FY2025 annual result came in at $9.7 million, down 38.78% from the prior year.
• Payables was $6.0 million for Q1 2026 at Bicycle Therapeutics, down from $9.7 million in the prior quarter.
• Across five years, Payables topped out at $18.3 million in Q2 2025 and bottomed at $2.8 million in Q1 2023.
• A 5-year average of $8.6 million and a median of $7.1 million in 2024 frame the typical range for Payables.
• Annual changes were most pronounced in 2022 — Payables soared 301.51% — and 2026, when it slumped 46.25%.
• Bicycle Therapeutics' Payables stood at $6.5 million in 2022, then jumped by 101.64% to $13.0 million in 2023, then increased by 21.02% to $15.8 million in 2024, then slumped by 38.78% to $9.7 million in 2025, then plunged by 38.26% to $6.0 million in 2026.
• Business Quant data shows BCYC's Payables at $6.0 million in Q1 2026, $9.7 million in Q4 2025, and $12.7 million in Q3 2025.